Orchestra BioMed Holdings, Inc. (OBIO)

Import this data to Google Sheets with:

=jivedata("OBIO","financials")

Full statements spill as a table. For one cell: =jivedata("OBIO","Revenue") or =jivedata("OBIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Orchestra BioMed Holdings, Inc.

OBIO • CIK 0001814114

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-51,506	$-64,301	$-51,807	$-57,991
Net Income (Loss) Attributable to Parent	$-49,120	$-61,024	$-52,701	$-59,029
Temporary Equity, Accretion to Redemption Value, Adjustment	—	—	$254	$254
Net Income (Loss) Available to Common Stockholders, Basic	—	—	$-52,955	$-59,572
Revenues	$2,760	$2,638	$33,482	$31,976
Cost of Revenue	$186	$204	$190	$157
Research and Development Expense	$33,822	$42,804	$58,185	$63,221
Selling, General and Administrative Expense	$20,258	$23,931	$26,914	$26,589
Costs and Expenses	$54,266	$66,939	$85,289	$89,967
Interest Income (Expense), Nonoperating, Net	—	$3,356	$-1,148	$-3,867
Gain (Loss) on Investments	$-18	$-68	$-68	$-68
Other Nonoperating Income (Expense)	—	$-11	$-11	$-11
Other Operating Income (Expense), Net	$2,386	$3,277	$-894	$-1,038
Weighted Average Number of Shares Outstanding, Basic	33,225,227	36,821,042	47,747,078	71,452,105
Marketable Securities, Unrealized Gain (Loss)	$-2	$62	$8	$-97
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-49,122	$-60,962	$-52,693	$-59,126

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$30,559	$22,261	$34,690	$20,472
Marketable Securities, Current	$56,968	$44,551	$71,822	$89,491
Property, Plant and Equipment, Net	$1,279	$1,384	$1,715	$2,045
Accounts Receivable, after Allowance for Credit Loss, Current	$99	$92	$95	$51
Operating Lease, Right-of-Use Asset	$1,555	$2,103	$1,496	$1,171
Inventory, Net	$146	$173	$310	$250
Equity Securities without Readily Determinable Fair Value, Amount	—	—	$2,495	$2,495
Prepaid Expense and Other Assets, Current	$1,274	$2,094	$994	$977
Assets, Current	$89,114	$69,171	$107,911	$111,241
Assets	$95,212	$76,173	$114,857	$115,700
Deferred Revenue, Noncurrent	$14,923	$10,989	$10,989	$8,659
Loans Payable, Noncurrent	$9,490	$14,292	$14,268	$14,397
Embedded Derivative, Fair Value of Embedded Derivative Liability	—	—	$2,749	$2,460
Operating Lease, Liability, Noncurrent	$1,038	$1,687	$936	$520
Other Liabilities, Noncurrent	$196	$40	$308	$397
Liabilities	$27,169	$43,215	$51,479	$86,280
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests	—	—	$9,808	$10,097
Accounts Payable, Current	$2,900	$5,134	$6,095	$6,132
Accrued Liabilities, Current	$5,149	$6,084	$9,890	$6,531
Operating Lease, Liability, Current	$649	$550	$751	$808
Deferred Revenue, Current	$2,510	$4,439	$4,439	$4,649
Liabilities, Current	$11,208	$16,207	$16,736	$13,471
Common Stock, Value, Issued	$4	$4	$6	$6
Additional Paid in Capital	$316,903	$342,780	$416,083	$426,423
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-10	$52	$60	$-81
Retained Earnings (Accumulated Deficit)	$-248,854	$-309,878	$-362,579	$-407,025
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$68,043	$32,958	$53,570	$19,323
Temporary Equity, Shares Issued	—	—	200,000	200,000
Temporary Equity, Liquidation Preference	—	—	$20,000	$20,000
Preferred Stock, Shares Authorized	10,000,000	10,000,000	10,000,000	10,000,000
Common Stock, Shares Authorized	340,000,000	340,000,000	340,000,000	340,000,000
Common Stock, Shares, Issued	35,777,412	38,194,442	57,032,963	60,105,049

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-49,120	$-61,024	$-52,701	$-59,029
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$10,775	$-8,298	$12,429	$1,723
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$30,559	$22,261	$34,690	$44,709
Depreciation, Depletion and Amortization	$287	$308	$327	$349
Share-based Payment Arrangement, Noncash Expense	$7,625	$10,615	$11,978	$11,119
Gain (Loss) on Investments	$-18	$-68	$-68	$-68
Accretion (Amortization) of Discounts and Premiums, Investments	$3,819	$1,501	$811	$1,126
Operating Lease, Right-of-Use Asset, Amortization Expense	$632	$654	$607	$635
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net	—	—	$254	$254
Amortization of Debt Issuance Costs	$112	$31	$215	$252
Other Noncash Income (Expense)	—	$-11	$-11	$-11
Increase (Decrease) in Accounts Receivable	$3	$-22	$3	$-32
Increase (Decrease) in Inventories	$-131	$28	$137	$66
Increase (Decrease) in Prepaid Expense and Other Assets	$781	$1,071	$-880	$-746
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$145	$2,969	$4,866	$667
IncreaseDecreaseInOperatingLeaseLiability	$-693	$-652	$-550	$-642
Increase (Decrease) in Contract with Customer, Liability	$-2,106	$-2,005	$-15,428	$-15,428
Net Cash Provided by (Used in) Operating Activities	$-46,127	$-50,558	$-48,963	$-58,320
Payments to Acquire Property, Plant, and Equipment	$78	$289	$489	$781
Proceeds from Sale and Maturity of Marketable Securities	$152,797	$86,628	$49,860	$56,248
Payments to Acquire Marketable Securities	$142,032	$72,648	$76,312	$129,535
Net Cash Provided by (Used in) Investing Activities	$10,687	$13,089	$-26,941	$-69,287
Proceeds from Issuance of Redeemable Convertible Preferred Stock	—	—	$12,557	$12,557
Proceeds from Issuance of Debt	$10,000	$15,000	$15,000	$15,000
Sale of Stock, Consideration Received on Transaction	—	$15,035	$1,543	$1,543
Proceeds from Stock Options Exercised	$231	$240	$91	$34
Payment, Tax Withholding, Share-based Payment Arrangement	—	$550	$1,552	$1,353
Net Cash Provided by (Used in) Financing Activities	$46,215	$29,171	$88,333	$129,330
Interest Paid, Including Capitalized Interest, Operating and Investing Activities	$1,119	$102	$1,447	$1,445
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	—	$1,202	$1,202	$1,202
Capital Expenditures Incurred but Not yet Paid	—	—	$169	$224
Stock Issued	—	$352	$352	$352

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("OBIO","financials")

Full statements spill as a table. For one cell: =jivedata("OBIO","Revenue") or =jivedata("OBIO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.